Latest Growth Strategy News

Ovanti Limited has completed a $1 million capital raise through a discounted share placement to accelerate its buy now, pay later business expansion in the United States.

True North Copper’s 2025 drilling at Mt Oxide confirms extensive copper-silver-cobalt mineralisation, validating new targets and underpinning a fully funded 2026 exploration program.

Finder Energy has completed its acquisition of the Petrojarl I FPSO, issuing over 37 million shares to Amplus Energy as part of the US$15 million deal. Amplus’ Managing Director joins Finder’s board, signalling deeper collaboration.

Unico Silver’s December quarter saw exceptional drill results at its Joaquin project and a $50 million capital raise, propelling the company into pre-feasibility studies and strengthening its development outlook.

Caprice Resources reports strong high-grade gold assay results from its Island Gold Project, confirming mineralisation continuity and new reef discoveries. Drilling has restarted to complete the Phase 4 programme, while exploration begins at the newly acquired Comet Project.

Forrestania Resources has completed an $18 million placement tranche and upscaled its oversubscribed Share Purchase Plan to $5 million, securing $23 million to advance its gold production strategy in Western Australia.

4DMedical Limited has raised AU$150 million to accelerate the commercial rollout of its FDA-cleared CT, VQ lung imaging technology in the US, leveraging a strategic partnership with Philips. This funding aims to expand adoption across major medical centres and government healthcare programs.

SportsHero Limited has reported its highest quarterly cash receipts since listing, driven by a milestone payment from its Philippines launch and rapid subscriber growth for its HeroPlay platform in Indonesia.

Alligator Energy has completed its Samphire pilot plant on time and under budget, setting the stage for a critical Field Recovery Trial in early 2026. The company also divested non-core Northern Territory assets to sharpen its focus and strengthen liquidity for its South Australian uranium projects.

Osteopore Limited has inked an exclusive collaboration with Majeton to commercialise its cutting-edge 3D-printed bioresorbable implants across China, Hong Kong, and Macau, unlocking significant growth potential in the region.

Vitasora Health has completed an A$11 million capital raise, including a cornerstone investment, bolstering its balance sheet to support ambitious growth in the US healthcare market. The company targets cash flow breakeven by the end of FY2026 amid expanding patient programs and new partnerships.

Osteopore Limited has secured an exclusive multi-year distribution agreement with Majeton to commercialise its dental and maxillofacial products in China, Hong Kong, and Macau, marking a major step in its Asia-Pacific expansion.